Acquisition to Open New Markets

Contract Manufacturing Organization (CMO) Indicia Production specialising in ready-to-use microbiological media and sterile pharmaceutical ingredients, has acquired Bio-Steril, a company focused on the formulation and Fill & Finish of medical devices for cosmetic and medical uses. 

This allows Indicia to extend its manufacturing capabilities and open new market areas, such as dermo-aesthetics, ophthalmology and rheumatology.  Created in June 2004, Bio-Steril produces sterile pre-filled syringes, vials and glassware in clean rooms of ISO 7 and ISO 8 standards, while filling is done under ISO 5 conditions. A wide variety of final packaging is available. The company is

Certified ISO13485.

“I am very happy with this new acquisition, which perfectly complements our current offer,” said Stephane Legastelois, chairman and CEO of Indicia Production. “Bio-Steril’s know-how will be very valuable to our customers.”

“Indicia Production is a well-known company and we are very pleased to join its ranks,” said René Trehorel, chairman of Bio-Steril. “We offer very specific know-how in sterilisation and production of sterile edical devices which will enhance Indicia’s global offer.

The consolidated company will operate with 85 employees. Its combined turnover for 2019 is estimated to reach €12.5M ($13.9M).